Tim Wilsdon and Ryan Lawlor are panelist during the session titled “Vaccines funding in Europe: Ensuring sustainability in a post-pandemic world.”
For more information on this event, click here.
This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
Tim Wilsdon and Ryan Lawlor are panelist during the session titled “Vaccines funding in Europe: Ensuring sustainability in a post-pandemic world.”
For more information on this event, click here.
MFN-related uncertainty is reshaping pharmaceutical launch planning by making pricing, sequencing, and forecasting decisions more interconnected and...
While advances in prevention, testing, and treatment have transformed outcomes for many people living with or at risk of HIV, significant inequities continue...
CRA is a proud sponsor of the conference. Greg Bell speaks during the session titled “Damages in Pharma & Biotech Litigation: What Courts are Accepting...
CRA is a proud sponsor of the event. Josh Sherman is a panelist during the session titled “Global antitrust trends reshaping the life sciences market”...
